Complete Filing Data
Lakefront Biotherapeutics NV reported Cash And Cash Equivalents of $87.87 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lakefront Biotherapeutics NV did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales And Marketing Expense | $6.1M | $17.2M | $5.7M | $3.5M | $3.8M | $66.5M | $24.6M | $4.1M | $2.8M | $1.8M | $1.2M |
| Research And Development Expense | $459.4M | $335.5M | $241.3M | $269.8M | $320.5M | $523.7M | $420.1M | $316.2M | $218.5M | $139.6M | $129.7M |
| Profit Loss From Operating Activities | $295.0M | -$188.3M | -$88.3M | -$131.1M | -$171.6M | -$178.6M | $368.7M | -$47.1M | -$89.8M | -$11.5M | -$89.4M |
| Profit Loss Before Tax | $300.9M | -$3.1M | $5.6M | -$70.8M | -$119.4M | -$309.8M | $148.5M | -$31.4M | -$115.5M | $54.2M | -$119.6M |
| Profit Loss Attributable To Owners Of Parent | $320.9M | $74.1M | $211.7M | -$218.0M | -$103.2M | -$305.4M | $149.8M | -$29.3M | -$115.7M | $54.0M | -$118.4M |
| Profit Loss | $320.9M | $74.1M | $211.7M | -$218.0M | -$103.2M | -$305.4M | $149.8M | -$29.3M | -$115.7M | $54.0M | -$118.4M |
| Other Comprehensive Income | -$6.0M | $7.4M | -$645.0K | $5.5M | $2.2M | -$8.1M | -$3.7M | $103.0K | -$924.0K | -$1.6M | $892.0K |
| Income Tax Expense Continuing Operations | -$18.6M | -$1.8M | $9.6M | $572.0K | $1.4M | $1.2M | -$165.0K | $822.0K | $198.0K | $235.0K | -$1.2M |
| General And Administrative Expense | $147.3M | $117.2M | $128.3M | $135.2M | $127.7M | $118.8M | $72.4M | $34.4M | $24.4M | $21.7M | $19.1M |
| Comprehensive Income Attributable To Owners Of Parent | $314.9M | $81.5M | $211.1M | -$212.5M | -$101.0M | -$313.5M | $146.2M | -$29.2M | -$116.6M | $52.4M | -$117.5M |
| Comprehensive Income | $314.9M | $81.5M | $211.1M | -$212.5M | -$101.0M | -$313.5M | $146.2M | -$29.2M | -$116.6M | $52.4M | -$117.5M |
| Non Current Research And Development Incentives Receivables | $126.7M | $132.7M | $141.3M | $119.9M | $127.2M | $111.6M | $93.4M | $73.4M | $64.0M | $54.2M | $49.4M |
| Income Taxes Paid Refund Classified As Operating Activities | $372.0K | -$406.0K | $8.2M | $4.4M | $684.0K | $1.4M | $57.0K | $8.0K | $199.0K | $1.8M | $94.0K |
| Current Research And Development Incentives Receivables | $31.2M | $39.9M | $37.4M | $26.1M | $16.8M | $24.1M | $21.9M | $11.2M | $11.8M | $10.2M | $9.2M |
| Revenue And Operating Income | $530.3M | $885.8M | $307.7M | $155.9M | $151.6M | $60.6M | |||||
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $653.0K | $246.0K | -$1.0M | $5.3M | $730.0K | -$6.1M | -$4.1M | -$94.0K | -$40.0K | -$583.0K | $202.0K |
| Profit Loss From Continuing Operations | $319.5M | -$1.3M | -$4.0M | -$71.4M | -$120.8M | -$311.0M | $148.7M | -$32.2M | |||
| Profit Loss From Discontinued Operations | $1.4M | $75.4M | $215.7M | -$146.6M | $17.6M | $5.6M | $1.2M | $3.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $87.9M | $64.2M | $166.8M | $508.1M | $2.23B | $2.14B | $1.86B | $1.29B | $1.15B | $973.2M | $340.3M | $187.7M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $13.7M | $16.7M | $18.7M | $27.4M | $54.2M | $42.5M | $22.4M | $10.4M | $5.3M | $4.5M | $6.1M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $155.0K | $65.4M | $567.0K | $9.6M | $3.7M | $48.8M | $23.3M | $3.3M | $2.1M | $332.0K | $565.0K | |
| Cash Flows From Used In Operations | -$307.9M | -$417.3M | -$463.9M | -$488.5M | -$493.5M | -$427.0M | $3.20B | -$146.0M | -$147.9M | $240.1M | -$115.6M | |
| Cash Flows From Used In Operating Activities | -$257.5M | -$320.0M | -$406.0M | -$500.5M | -$503.8M | -$427.3M | $3.21B | -$142.5M | -$147.0M | $239.4M | -$114.6M | |
| Cash Flows From Used In Investing Activities | $288.8M | $220.6M | $71.2M | -$1.25B | $541.2M | $757.3M | -$3.76B | -$15.9M | -$549.0K | -$7.3M | -$4.3M | |
| Cash Flows From Used In Financing Activities | -$3.3M | -$4.9M | -$5.0M | -$1.5M | -$3.9M | $22.0M | $1.34B | $287.9M | $353.4M | $396.0M | $271.4M | |
| Trade And Other Current Receivables | $20.7M | $47.5M | $28.4M | $40.4M | $111.3M | $148.4M | $54.0M | $18.6M | $28.0M | $9.7M | $3.9M | |
| Trade And Other Current Payables | $104.6M | $98.9M | $135.2M | $148.7M | $137.6M | $175.6M | $143.4M | $68.9M | $48.3M | $31.9M | $29.5M | |
| Retained Earnings | $210.6M | -$134.3M | -$228.3M | -$496.7M | -$367.2M | -$334.7M | -$109.2M | -$297.8M | -$211.4M | -$112.3M | -$177.3M | |
| Other Noncurrent Assets | $3.0M | $8.7M | $16.1M | $5.8M | $2.5M | $11.3M | $14.1M | $7.9M | $3.5M | $4.0M | $557.0K | |
| Other Current Assets | $7.0M | $31.0M | $15.1M | $23.3M | $9.9M | $11.9M | $9.1M | $8.2M | $6.7M | $14.1M | $5.5M | |
| Noncurrent Liabilities | $17.8M | $903.7M | $1.13B | $1.69B | $1.98B | $2.41B | $2.62B | $5.3M | $102.6M | $220.8M | $5.1M | |
| Noncurrent Assets | $327.1M | $796.3M | $495.8M | $497.5M | $331.3M | $348.4M | $202.7M | $110.6M | $88.6M | $76.1M | $68.0M | |
| Liabilities | $170.7M | $1.24B | $1.56B | $2.21B | $2.55B | $3.05B | $3.19B | $225.2M | $274.3M | $324.6M | $77.5M | |
| Intangible Assets Other Than Goodwill | $848.0K | $164.9M | $127.9M | $146.4M | $60.1M | $67.6M | $24.9M | $3.6M | $2.5M | $1.0M | $1.6M | |
| Increase Decrease Through Exercise Of Warrants Equity | $1.8M | $6.7M | $3.3M | $28.3M | $17.2M | $7.7M | $5.3M | $4.3M | $12.0M | |||
| Equity And Liabilities | $3.41B | $4.14B | $4.36B | $4.73B | $5.19B | $5.72B | $6.07B | $1.44B | $1.29B | $1.08B | $442.5M | |
| Deferred Tax Assets | $195.0K | $1.5M | $1.1M | $1.4M | $4.0M | $4.5M | $4.2M | $2.5M | $2.0M | $2.0M | $1.7M | |
| Current Liabilities | $152.9M | $335.1M | $428.2M | $522.5M | $566.5M | $635.3M | $571.8M | $219.9M | $171.7M | $103.8M | $72.4M | |
| Current Assets | $3.08B | $3.34B | $3.86B | $4.24B | $4.86B | $5.37B | $5.87B | $1.33B | $1.20B | $1.01B | $374.5M | |
| Assets | $3.41B | $4.14B | $4.36B | $4.73B | $5.19B | $5.72B | $6.07B | $1.44B | $1.29B | $1.08B | $442.5M | |
| Noncurrent Recognised Liabilities Defined Benefit Plan | $2.1M | $2.3M | $5.5M | $11.7M | $15.0M | $8.3M | $3.8M | $3.6M | $3.5M | $2.7M | ||
| Current Tax Liabilities | $956.0K | $249.0K | $56.0K | $1.0M | $1.8M | $1.2M | $2.0M | $1.2M | $865.0K | $1.0M | $2.6M | |
| Other Noncurrent Liabilities | $12.6M | $33.8M | $31.6M | $7.1M | $8.1M | $7.0M | $1.6M | $1.7M | $2.5M | $2.3M | ||
| Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | -$42.3M | -$76.2M | -$16.7M | -$3.8M | -$28.8M | -$2.5M | -$5.1M | -$668.0K | -$14.0K | |||
| Adjustment For Items To Disclose Separately Under Operating Cash Flow | -$63.4M | -$89.6M | -$65.8M | -$4.5M | $11.2M | $4.1M | -$7.7M | -$4.4M | -$1.9M | -$1.3M | ||
| Current Lease Liabilities | $1.7M | $3.5M | $4.7M | $7.2M | $7.2M | $6.4M | $5.8M | $0.00 | $9.0K | |||
| Noncurrent Lease Liabilities | $5.2M | $8.2M | $4.9M | $14.7M | $19.7M | $23.0M | $19.6M | $0.00 | ||||
| Current Investments | $2.91B | $3.05B | $3.52B | $3.59B | $2.47B | $3.03B | $3.92B | $0.00 | ||||
| Cash And Cash Equivalents Including Discontinued Operations | $87.9M | $64.2M | $166.8M | $508.1M | $2.23B | $2.14B | $1.86B | $1.29B | ||||
| Adjustment For Non Cash Transactions | $99.3M | $117.3M | $57.7M | $230.7M | $248.0M | $21.8M | $48.3M | -$47.5M | ||||
| Deferred Income Classified As Current | $443.2M | $414.3M | $149.8M | $122.5M | $70.8M | $39.8M | ||||||
| Adjustments For Increase Decrease In Deferred Income | -$207.8M | $2.80B | -$153.3M | -$65.7M | $245.8M | $12.8M | ||||||
| Current Financial Investments And Cash And Cash Equivalents | $4.09B | $4.70B | $5.17B | $5.78B | $1.29B | $1.15B | ||||||
| Purchase Of Availableforsale Financial Assets | $14.0M | $2.7M | $177.0K | $4.6M | $2.8M | |||||||
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | $3.08B | $3.33B | $3.84B | $4.24B | $4.86B | $5.35B | $5.87B | $1.33B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$4.5M | $1.8M | -$1.5M | $22.3M | $56.8M | -$70.5M | -$10.0M | $10.1M | -$27.8M | $4.8M | $118.0K |
| Proceeds From Exercise Of Warrants | $1.8M | $6.7M | $3.3M | $28.3M | $17.2M | $7.7M | $5.3M | $4.3M | $12.0M | ||
| Increase Decrease In Working Capital Excluding Deferred Income | -$149.3M | $61.4M | $31.4M | -$32.3M | -$23.3M | $146.1M | $12.7M | -$19.9M | -$12.9M | -$10.9M | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $462.0K | $3.0K | $2.4M | $739.0K | $49.0K | $0.00 | $0.00 | $7.0K | |||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $28.1M | -$104.4M | -$339.8M | -$1.75B | $33.5M | $352.0M | $779.7M | $129.5M | $205.8M | ||
| Payments Of Lease Liabilities Classified As Financing Activities | $3.3M | $4.9M | $6.8M | $8.2M | $7.2M | $6.2M | $5.1M | $5.0K | |||
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | $4.0M | $6.6M | $82.0K | $2.4M | $372.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $4.87 | $1.12 | $3.21 | $-3.32 | $-1.58 | $-4.69 | $2.49 | $-0.56 | $-2.34 | $1.14 | $-3.32 |
| Basic Earnings Loss Per Share | $4.87 | $1.12 | $3.21 | $-3.32 | $-1.58 | $-4.69 | $2.60 | $-0.56 | $-2.34 | $1.18 | $-3.32 |
| Weighted Average Shares | 65.9M | 65.9M | 65.9M | 65.7M | 65.5M | 65.1K | 57.6K | 52.1K | 49.5M | 45.7M | 35.7M |
| Basic Earnings Loss Per Share From Continuing Operations | $4.85 | $-0.02 | $-0.06 | $-1.09 | $-1.84 | $-4.78 | $2.58 | $-0.62 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Finance Cost | $2.9M | $1.7M | $2.6M | $9.9M | $12.4M | $26.5M | $60.0M | $2.6M | $30.6M | $1.7M | $1.5M | |
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$475.0K | $578.0K | $392.0K | $129.0K | $736.0K | -$1.0M | $415.0K | $197.0K | -$664.0K | -$623.0K | $690.0K | |
| Other Reserves | -$8.6M | -$3.2M | -$5.9M | -$4.9M | -$10.2M | -$10.9M | -$4.8M | -$735.0K | -$1.3M | -$1.0M | -$18.0K | -$220.0K |
| Interest Received Classified As Operating Activities | $51.3M | $97.5M | $69.9M | $4.8M | $2.9M | $10.1M | $7.9M | $4.6M | $1.3M | $1.1M | $1.1M | |
| Interest Paid Classified As Operating Activities | $464.0K | $689.0K | $3.8M | $12.5M | $12.5M | $9.0M | $1.2M | $1.1M | $273.0K | $47.0K | $49.0K | |
| Increase Decrease Through Sharebased Payment Transactions | $24.0M | $19.9M | $56.7M | $88.5M | $70.7M | $80.0M | $38.3M | $26.8M | $16.5M | $11.0M | $5.0M | |
| Share Premium | $2.74B | $2.74B | $2.74B | $2.74B | $2.73B | $2.73B | $2.70B | $1.28B | $993.0M | $649.1M | $357.4M | $114.2M |
| Reserve Of Exchange Differences On Translation | $3.0M | $3.5M | -$1.2M | -$1.6M | -$1.7M | -$3.2M | -$1.1M | -$1.6M | -$1.8M | -$1.1M | -$467.0K | -$1.2M |
| Other Finance Income | $48.1M | $91.1M | $80.2M | $18.6M | $3.1M | $11.6M | $21.4M | $18.3M | $4.9M | $10.0M | $2.0M | |
| Issued Capital | $293.9M | $293.9M | $293.9M | $293.6M | $292.1M | $291.3M | $287.3M | $236.5M | $233.4M | $223.9M | $185.4M | $157.3M |
| Other Income | $52.2M | $50.9M | $29.0M | $28.8M | $22.1M | $21.0M | ||||||
| Operating Expense | $708.9M | $517.0M | $354.7M | $245.7M | $163.1M | $150.0M |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.